Sumber Anekakarya Abadi is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1987. Sumber Anekakarya Abadi is a prominent player in the Indonesian pharmaceutical industry, known for its commitment to quality and innovation. The company was founded by a group of visionary entrepreneurs who aimed to address the growing healthcare needs in Indonesia. Over the years, Sumber Anekakarya Abadi has expanded its operations to include both primary and secondary business lines, focusing on the manufacturing and distribution of pharmaceutical products. The company operates several branches across Indonesia, ensuring a strong local geographical footprint. Its main product types include prescription medications, over-the-counter drugs, and health supplements, marketed under well-recognized brand names. Sumber Anekakarya Abadi is dedicated to improving public health and has established a reputation for producing safe and effective pharmaceutical solutions. Internationally, the company has extended its reach to several countries in Southeast Asia, contributing to its global geographical footprint. Sumber Anekakarya Abadi collaborates with various international pharmaceutical companies and is a member of several industry associations, which helps it stay at the forefront of pharmaceutical advancements. The company is committed to sustainable practices and innovation, with a mission to enhance the quality of life through accessible healthcare solutions. Sumber Anekakarya Abadi's vision is to become a leading pharmaceutical company in the region, known for its dedication to health and wellness.
Headquarters
Jl. Batu Ceper No. 2 B-C-D
Central Jakarta; Jakarta;
Postal Code: 10120
Contact Details: Purchase the PT Sumber Anekakarya Abadi report to view the information.
Website: http://www.saka.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service